TGV Sraac Ltd
TGV Sraac Ltd is engaged in the production of chlor-alkali products, chloromethane, castor derivatives and fatty acids.[1]
It is the flagship company of TGV group which has presence in industries such as healthcare products, aqua culture, real estate, pharmaceuticals, industrial chemicals and hospitality. [2]
- Market Cap ₹ 1,240 Cr.
- Current Price ₹ 116
- High / Low ₹ 182 / 58.0
- Stock P/E 3.52
- Book Value ₹ 92.6
- Dividend Yield 0.00 %
- ROCE 22.4 %
- ROE 19.8 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is expected to give good quarter
- Company has delivered good profit growth of 51.8% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 10.9% over past five years.
- Company has a low return on equity of 12.0% over last 3 years.
- Debtor days have increased from 40.2 to 55.6 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chlor Alkali / Soda Ash
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
702 | 782 | 817 | 769 | 777 | 816 | 908 | 1,046 | 1,205 | 1,040 | 1,009 | 1,525 | 2,175 | |
604 | 681 | 695 | 670 | 669 | 710 | 776 | 866 | 974 | 884 | 860 | 1,204 | 1,608 | |
Operating Profit | 99 | 101 | 121 | 99 | 108 | 107 | 132 | 180 | 231 | 157 | 149 | 322 | 567 |
OPM % | 14% | 13% | 15% | 13% | 14% | 13% | 15% | 17% | 19% | 15% | 15% | 21% | 26% |
5 | 5 | 4 | -19 | 0 | 5 | 9 | 7 | -6 | 8 | 10 | 7 | 7 | |
Interest | 42 | 42 | 45 | 40 | 40 | 44 | 60 | 58 | 71 | 44 | 48 | 51 | 51 |
Depreciation | 34 | 37 | 41 | 36 | 36 | 35 | 47 | 77 | 58 | 56 | 63 | 69 | 72 |
Profit before tax | 27 | 28 | 40 | 4 | 32 | 33 | 34 | 53 | 95 | 64 | 48 | 209 | 450 |
Tax % | 50% | 50% | 6% | -11% | 30% | 26% | 52% | 44% | 28% | 26% | 40% | 36% | |
Net Profit | 14 | 14 | 38 | 5 | 22 | 24 | 17 | 30 | 68 | 47 | 29 | 134 | 352 |
EPS in Rs | 5.31 | 0.64 | 2.81 | 2.95 | 1.90 | 3.22 | 7.08 | 4.65 | 2.70 | 12.53 | 32.88 | ||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 11% |
3 Years: | 8% |
TTM: | 102% |
Compounded Profit Growth | |
---|---|
10 Years: | 25% |
5 Years: | 52% |
3 Years: | 20% |
TTM: | 859% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | 12% |
3 Years: | 70% |
1 Year: | 79% |
Return on Equity | |
---|---|
10 Years: | 11% |
5 Years: | 12% |
3 Years: | 12% |
Last Year: | 20% |
Balance Sheet
Figures in Rs. Crores
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
86 | 86 | 90 | 94 | 98 | 102 | 106 | 92 | 97 | 102 | 107 | 107 | 107 | |
Reserves | 121 | 135 | 172 | 177 | 199 | 227 | 258 | 290 | 373 | 430 | 503 | 636 | 885 |
331 | 385 | 322 | 313 | 327 | 432 | 457 | 439 | 328 | 420 | 499 | 461 | 312 | |
196 | 207 | 212 | 231 | 213 | 230 | 276 | 269 | 298 | 323 | 344 | 393 | 384 | |
Total Liabilities | 715 | 794 | 777 | 796 | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,688 |
380 | 460 | 456 | 431 | 444 | 660 | 698 | 669 | 636 | 808 | 774 | 902 | 924 | |
CWIP | 103 | 53 | 70 | 126 | 124 | 0 | 0 | 13 | 77 | 29 | 125 | 55 | 60 |
Investments | 2 | 2 | 2 | 2 | 2 | 2 | 9 | 14 | 10 | 8 | 89 | 89 | 117 |
231 | 279 | 250 | 237 | 248 | 309 | 371 | 394 | 373 | 430 | 465 | 551 | 587 | |
Total Assets | 715 | 794 | 777 | 796 | 818 | 972 | 1,078 | 1,091 | 1,095 | 1,275 | 1,453 | 1,598 | 1,688 |
Cash Flows
Figures in Rs. Crores
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
133 | 105 | 27 | 78 | 65 | 50 | 142 | 153 | 202 | 122 | 132 | 213 | |
-83 | -67 | -53 | -75 | -52 | -132 | -109 | -75 | -55 | -188 | -163 | -147 | |
-44 | -2 | -3 | -12 | -2 | 91 | -33 | -76 | -145 | 65 | 58 | -83 | |
Net Cash Flow | 7 | 36 | -29 | -9 | 11 | 9 | -0 | 2 | 2 | -0 | 26 | -18 |
Ratios
Figures in Rs. Crores
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 37 | 31 | 27 | 25 | 25 | 29 | 30 | 37 | 30 | 29 | 36 | 56 |
Inventory Days | 61 | 71 | 60 | 77 | 50 | 82 | 79 | 89 | 125 | 167 | 126 | 101 |
Days Payable | 68 | 66 | 74 | 93 | 65 | 77 | 98 | 80 | 67 | 73 | 81 | 66 |
Cash Conversion Cycle | 30 | 36 | 13 | 8 | 10 | 34 | 11 | 45 | 89 | 123 | 81 | 90 |
Working Capital Days | 18 | 16 | 3 | -9 | -1 | 21 | 7 | 11 | 35 | 46 | 37 | 54 |
ROCE % | 14% | 12% | 14% | 12% | 13% | 11% | 12% | 13% | 22% | 12% | 9% | 22% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 10 Jan
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Jan - Submission of Compliance certificate under Reg.74(5) of SEBI (DP) Reg.2018 for quarter ending 31.12.2022.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 29 Dec
- Closure of Trading Window 28 Dec 2022
- Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Meeting Updates. 2 Dec 2022
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Chemicals Segment (~87% of revenues)[1]
Under the segment, the company manufactures chemicals like caustic soda, (lye & flakes), potassium hydroxide, chlorine, hydro chloric acid, etc.[2]